Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11701
CPS Technologies
CPSH
$74.8M
| $116K | ﹤0.01% |
41,810
+20,193
| +93% | +$43.1K |
|
11702
CALL
Lexicon Pharmaceuticals
LXRX
$1.03B
| $116K | ﹤0.01% |
121,800
+75,700
| +164% | +$49K |
|
|
NVNO
11703
CALL
enVVeno Medical
NVNO
$7.97M
| $116K | ﹤0.01% |
+829
| New | +$98K |
|
11704
CALL
Telecom Argentina
TEO
$5.75B
| $116K | ﹤0.01% |
+13,100
| New | +$131K |
|
11705
Genasys
GNSS
$70.1M
| $116K | ﹤0.01% |
66,840
-243,887
| -78% | -$450K |
|
|
JAMF
11706
PUT
DELISTED
Jamf
JAMF
| $115K | ﹤0.01% |
12,100
+1,600
| +15% | +$17.2K |
|
11707
PUT
James River Group Holdings
JRVR
$191M
| $115K | ﹤0.01% |
19,600
+7,100
| +57% | +$36K |
|
11708
Better Online Solutions
BOSC
$32.1M
| $115K | ﹤0.01% |
+23,664
| New | +$97K |
|
|
ABX
11709
CALL
Abacus Global Management
ABX
$956M
| $115K | ﹤0.01% |
22,300
+8,900
| +66% | +$65.7K |
|
11710
CALL
TransAlta
TAC
$4B
| $114K | ﹤0.01% |
10,600
-143,100
| -93% | -$1.36M |
|
|
REE
11711
CALL
DELISTED
REE Automotive
REE
| $114K | ﹤0.01% |
190,500
+30,700
| +19% | +$54K |
|
11712
PUT
BuzzFeed
BZFD
$90M
| $113K | ﹤0.01% |
56,400
-22,400
| -28% | -$44.2K |
|
11713
CALL
Galectin Therapeutics
GALT
$419M
| $112K | ﹤0.01% |
53,300
-401,700
| -88% | -$601K |
|
11714
PUT
Annovis Bio
ANVS
$75.8M
| $112K | ﹤0.01% |
51,800
-21,900
| -30% | -$43.2K |
|
11715
TriSalus Life Sciences
TLSI
$304M
| $112K | ﹤0.01% |
+20,558
| New | +$110K |
|
11716
CALL
Full House Resorts
FLL
$79.9M
| $112K | ﹤0.01% |
30,600
-56,400
| -65% | -$189K |
|
|
AHRT
11717
PUT
AH Realty Trust
AHRT
$501M
| $112K | ﹤0.01% |
16,300
-23,200
| -59% | -$161K |
|
11718
CALL
Quad
QUAD
$515M
| $112K | ﹤0.01% |
19,800
+3,000
| +18% | +$16.2K |
|
|
BLE
11719
DELISTED
BlackRock Municipal Income Trust II
BLE
| $112K | ﹤0.01% |
11,133
-8,176
| -42% | -$81.6K |
|
|
BRW
11720
Saba Capital Income & Opportunities Fund
BRW
$329M
| $112K | ﹤0.01% |
13,860
| – | – |
|
11721
Century Therapeutics
IPSC
$388M
| $112K | ﹤0.01% |
199,951
+142,516
| +248% | +$76.5K |
|
11722
PUT
JELD-WEN Holding
JELD
$210M
| $111K | ﹤0.01% |
28,400
+16,700
| +143% | +$74.4K |
|
11723
PUT
Blink Charging
BLNK
$85.9M
| $111K | ﹤0.01% |
118,100
-104,600
| -47% | -$83.5K |
|
11724
CALL
Sasol
SSL
$7.28B
| $111K | ﹤0.01% |
25,100
+7,500
| +43% | +$30.7K |
|
|
LOMA
11725
PUT
Loma Negra
LOMA
$1.13B
| $111K | ﹤0.01% |
10,100
-46,700
| -82% | -$540K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2025 filing shows 1,720 new, 5,716 increased, 5,055 reduced and 1,538 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.